Market Share of Global Skin Cancer Diagnostics and Therapeutics Industry
The skin cancer diagnostics and therapeutics market is competitive globally and regionally. The market consists of several major players who are engaged in continuous product development and launches. Some companies currently dominating the market are Abbott, Pfizer Inc., Sanofi SA, F. Hoffmann-La Roche Ltd, Labcorp., and sun pharmaceuticals industries limited, among others.
Skin Cancer Diagnostics and Therapeutics Market Leaders
Amgen, Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd
Merck & Co., Inc.
Sun Pharmaceutical Industries Ltd
*Disclaimer: Major Players sorted in no particular order
